跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,372 条关于
“VIS-101”
全部
16,372
临床试验
8,608
药物
5,416
机构
36
资讯
2,312
6个月前
NovaBridge's VIS-101 Shows Promising Phase 2a Results in Wet AMD with Potential Best-in-Class Durability
10个月前
NovaBridge Subsidiary Visara Assigns VIS-101 License to Everest Medicines for Asian Markets
11个月前
I-Mab Announces Strategic Transformation to NovaBridge Biosciences with Hong Kong IPO Plans and VIS-101 Acquisition
上个月
NovaBridge to Report First Half 2026 Results and Corporate Update on August 20
去年
FDA Clears Gentuity's HF-OCT Imaging System for Coronary Interventions
11个月前
Vascarta Completes Phase 1 Trial of Topical Curcumin Gel VAS-101 for Knee Osteoarthritis
去年
Endeavor BioMedicines' ENV-101 Shows Promise in Reversing Idiopathic Pulmonary Fibrosis in Phase II Trials
去年
Spirovant Sciences Doses First Patient in Phase 1/2 Trial of SP-101 Gene Therapy for Cystic Fibrosis
去年
Oxcia Prioritizes OXC-101 Development for Hematological Cancers, Focusing on AML
5个月前
Vascarta's Topical Curcumin Gel VAS-101 Shows Significant Pain Reduction in Knee Osteoarthritis Phase 1b Trial
第 1 页,共 232 页
上一页
下一页